Creation of a database for evaluating the effect of genetic intellectual property on genetic diagnostic testing [PDF]
Thesis (S.B.)--Massachusetts Institute of Technology, Dept. of Mechanical Engineering, 2006.Includes bibliographical references (leaves 33-34).In this study, we explore the impact of gene-based patents on the pricing and availability of genetic ...
Murray, Philip (Philip E.)
core
Central Nervous System Vascular Malformations [PDF]
32 page ...
Andrew S. Davidson, Marcus A. Stoodley
core +2 more sources
Cerebral Cavernous Malformations: An Update on Prevalence, Molecular Genetic Analyses, and Genetic Counselling [PDF]
Based on the latest gnomAD dataset, the prevalence of symptomatic hereditary cerebral cavernous malformations (CCMs) prone to cause epileptic seizures and stroke-like symptoms was re-evaluated in this review and calculated to be 1:5,400-1:6,200 ...
Felbor, Ute +3 more
core +1 more source
Congenital vascular malformations update [PDF]
Presently, there is controversy and misconception in the diagnosis and management of most congenital vascular malformations. The aim of this manuscript is to identify the current knowledge of these poorly understood and relatively uncommon pathologies ...
Albores Figueroa, Rosemberg +4 more
core
Familial Cerebral Cavernous Malformation in a Filipino Familye
Background of the Study Cerebral cavernous malformation is a type of vascular malformations characterized by the absence of intervening brain parenchyma. Cerebral cavernous malformations are of two forms, sporadic and familial. About 0.4-0.8% of the population are affected as assessed based on MRI findings and postmortem findings.
Maria Veronica Comandao - +1 more
openaire +1 more source
Fetal Familial Cerebral Cavernous Malformation With a Novel Heterozygous KRIT1 Pathogenic Variant [PDF]
OBJECTIVES: To identify fetal familial cerebral cavernous malformation (CCMs) and a novel mutation. METHODS: A 37-year-old pregnant woman (G4P0) presented right-handed numbness since two weeks at 31 weeks of gestation.
Barkhof, F +4 more
core
BackgroundThe Phase 1/2 Treat_CCM randomized controlled trial for people with familial cerebral cavernous malformations (FCCMs) confirmed the safety of propranolol and suggested beneficial effects on intracerebral hemorrhage or new focal neurological ...
Jennifer M. T. A. Meessen +14 more
doaj +1 more source
Natural history of familial cerebral cavernous malformation syndrome in children: a multicenter cohort study. [PDF]
Geraldo AF +15 more
europepmc +1 more source
A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition [PDF]
We have studied a family with severe mental retardation characterized by the virtual absence of speech, autism spectrum disorder, epilepsy, late-onset ataxia, weakness and dystonia.
Feldman, Gerald +9 more
core
Circulating Plasma miRNA Homologs in Mice and Humans Reflect Familial Cerebral Cavernous Malformation Disease. [PDF]
Romanos SG +29 more
europepmc +1 more source

